Bioven Mono (Human normal immunoglobulin) solution for injections 25 ml. vial №1

$179.00

Manufacturer: Poland

Purpose: Boosts immunity by providing human normal immunoglobulin for infections.

SKU: MED56750 Category:

Description

Bioven Mono (Human normal immunoglobulin) Solution for Injections 25 ml Vial №1

Composition

Bioven Mono contains Human normal immunoglobulin as the active ingredient.

Mechanism of Action

Human normal immunoglobulin works by providing passive immunity to individuals who are deficient in antibodies. It helps in fighting infections and maintaining overall immune health.

Pharmacological Properties

Human normal immunoglobulin products like Bioven Mono can effectively boost the immune system in patients with immunodeficiency disorders.

Indications for Use

  • Treatment of primary immunodeficiency disorders
  • Autoimmune deficiencies
  • Certain neurological disorders

Contraindications

Do not use Bioven Mono if you have a history of hypersensitivity to human immunoglobulins or any component of the product.

Side Effects

No common side effects reported. However, consult a healthcare professional for personalized information.

Usage Instructions

Bioven Mono should be administered intravenously under the supervision of a healthcare professional. Dosage should be determined based on the patient’s condition.

Benefits Compared to Analogues

Bioven Mono has shown efficacy in improving the quality of life for patients with immunodeficiency disorders by reducing infection frequency and severity.

Suitable Patient Groups

Suitable for children, adults, and elderly individuals with immunodeficiency disorders.

Storage and Shelf Life

Store Bioven Mono in a refrigerator between 2°C to 8°C. Do not freeze. Keep out of reach of children. Shelf life as indicated on the packaging.

Packaging Description

Bioven Mono is available in a 25 ml vial for injections.

Clinical Evidence and Proven Effectiveness

Clinical studies have shown that Bioven Mono is effective in enhancing the immune response in patients with immunodeficiency disorders. It has demonstrated a reduction in infection rates and improved overall health outcomes.